Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis
- 27 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer
- Vol. 27 (5), 903-911
- https://doi.org/10.1007/s12282-020-01086-z
Abstract
Background Triple-negative breast cancer (TNBC) is one of the leading causes of death among females around the world. However, the molecular mechanism of the disease among TNBC patients remains to be further studied. Methods In our study, four microarray data and two high throughput sequencing data were acquired from the GEO database, and the differentially expressed genes (DEGs) between TNBC and normal tissues had been analyzed. Analysis of functional enrichment and pathway enrichment of DEGs was conducted by the Funrich software, and protein–protein interaction (PPI) network gained from the STRING, and hub genes were confirmed by the Cytoscape. Kaplan–Meier plotter (KM plotter) online dataset had been used to analyze DEGs of overall survival (OS), and progression-free survival (PFS). Results In total, 1638 DEGs were gained in our study covering 984 upregulated and 654 downregulated genes. Moreover, a PPI network was constructed, and cyclin-dependent kinase 1 (CDK1), cyclin B1 (CCNB1), and cyclin A2 (CCNA2) were found as top genes with higher node degrees. CDK1, CCNA2, and CCNB1were obviously enriched in the cell cycle. The top upregulated genes including CDK1, CCNB1, CCNA2, and PLK1 were overexpressed in TNBC, and correlated with worse OS in breast cancer. High expression of CCNB1 was correlated with worse PFS in TNBC (HR = 1.42, 95% CI: 1.04–1.94, P = 0.028). Besides, there was a correlation between CCNB1 and CDK1 in TNBC, as well as between CCNA2 and CDK1 (r = 0.804, P < 0.001; r = 0.577, P < 0.001, respectively). Conclusion Our results suggest that cyclin CDK1, CCNB1, and CCNA2 are overexpressed in TNBC and they could act as novel biomarkers for the diagnosis and treatment of TNBC.Keywords
Funding Information
- National Natural Science Foundation of China (NO. 81802269)
This publication has 32 references indexed in Scilit:
- miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast CancerPLOS ONE, 2013
- Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast CancerCancer Research, 2013
- Cyclins and Cell Cycle Control in Cancer and DiseaseGenes & Cancer, 2012
- A novel function for Cyclin A2: Control of cell invasion via RhoA signalingThe Journal of cell biology, 2012
- Shared and separate functions of polo-like kinases and aurora kinases in cancerNature Reviews Cancer, 2010
- Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast CancerClinical Cancer Research, 2009
- High cyclin B1 expression is associated with poor survival in breast cancerBritish Journal of Cancer, 2009
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cellsThe International Journal of Biochemistry & Cell Biology, 2006
- Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinasesNature, 1995